Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Prostate Cancer treatment details. Biologic therapy. Chemotherapy. Kenneth J. Norris Comprehensive Cancer Center, Los Angeles, CA, United States

Survival: 16.0 months
Toxicity Grade: 3
Treatments: Biologic therapy
Country: United States
City/State/Province: Los Angeles, CA
Hospital: Kenneth J. Norris Comprehensive Cancer Center
Journal: Link
Date: 12/2008

Patients: This phase 2 study involved 19 patients with androgen-independent prostate cancer. Their median age was 70, ranging from 52 to 83 years of age.

Treatment: These patients were treated with the chemotherapy drug mitoxantrone, calcitriol (a type of vitamin D), and prednisone (a corticosteroid or biological therapy).

Toxicity: Grade 3 toxicities (neutropenia/leucopenia, fatigue, and temporary loss of consciousness) occurred in one patient each. One grade 4 toxicity, pulmonary embolism, was also reported.

Results: The median overall survival was 16 months (ranging from 6 to 26 months).

Support: This study was supported by research funds from Novacea Inc. which developed the form of calcitriol used in this study and OSI Pharmaceuticals, which markets mitoxantrone as NovantroneŽ.

Correspondence: Dr. Christopher W. Ryan

E-mail to a Friend Email Physician More Information